Adrian Vella, MD
Mayo Clinic · Mayo Clinic & Foundation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adrian Vella, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:35 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06976619 · The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesMayo Clinic · recruiting · Type 1 Diabetes, Type 2 Diabetes · principal investigator
- Ph2NCT06972407 · The Effect of rs7903146 Genotype on Islet GLP-1 Production in HumansMayo Clinic · not yet recruiting · Genetic Predisposition, Type2diabetes · principal investigator
- Ph2NCT06967558 · The Role of Islet GLP-1 in the Pathogenesis of PrediabetesMayo Clinic · recruiting · PreDiabetes · principal investigator
- N/ANCT06424015 · Insulin and Insulin Pulses During FastingMayo Clinic · recruiting · PreDiabetes · principal investigator
- N/ANCT06424106 · Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 DiabetesMayo Clinic · recruiting · PreDiabetes · principal investigator
- Ph4NCT05264727 · Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid InfusionMayo Clinic · active not recruiting · Healthy, Type 2 Diabetes, Obesity · principal investigator
- Ph3NCT04466566 · A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in NondiabeticsAdrian Vella · completed · Healthy · principal investigator
- Ph3NCT04459338 · A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin SecretionAdrian Vella · completed · Healthy · principal investigator
- Ph1/Ph2NCT03999853 · Butyrate Adjuvant Therapy for Type 1 DiabetesMayo Clinic · completed · Type1diabetes · principal investigator
- Ph4NCT03998709 · Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin SecretionMayo Clinic · withdrawn · Healthy · principal investigator
- Ph1NCT02128581 · A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food IntakeMayo Clinic · completed · Obesity, Diabetes, Roux-en-Y Gastric Bypass · principal investigator
- Ph1NCT01218633 · Dose-response Study of Exendin-9,39 on Glucose MetabolismAdrian Vella · completed · Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1 · principal investigator
- N/ANCT01117311 · Vagal Nerve Stimulation and Glucose MetabolismMayo Clinic · completed · Type 2 Diabetes, Obesity, Gastric Emptying · principal investigator
- Ph4NCT01094054 · Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight LossMayo Clinic · completed · Obesity, Diabetes · principal investigator
- Ph4NCT00951899 · The Effect of Welchol on Glucose Metabolism in Type 2 DiabeticsMayo Clinic · completed · Type 2 Diabetes · principal investigator
- Ph2NCT00850161 · Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous InsulinCPEX Pharmaceuticals Inc. · withdrawn · Type 1 Diabetes Mellitus · principal investigator
- N/ANCT00707616 · Common Genetic Variation and Type 2 DiabetesMayo Clinic · completed · Pre-diabetes · principal investigator
- Ph4NCT00588172 · Genetic Variation in OCT1 and Response to MetforminMayo Clinic · withdrawn · Type 2 Diabetes · principal investigator
- N/ANCT00588380 · GLP1R Polymorphisms and Response to GLP1Mayo Clinic · completed · Diabetes · principal investigator
- Ph3NCT00351507 · A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 DiabetesNovartis Pharmaceuticals · completed · Diabetes Mellitus, Type 2 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Glucagon secretion and action in humansR01DK116231 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · fiscal years 2017 to 2026Named on NCT05264727
- The effect of endogenous GLP-1 secretion on islet function in vivoR01DK126206 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · fiscal years 2020 to 2026Named on NCT04466566, NCT04459338
- The regulation of fasting glucose metabolism in people with and without prediabetesR01DK078646 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · fiscal years 2007 to 2026Named on NCT03998709, NCT00951899
- The Effect of Bariatric Surgery on Carbohydrate MetabolismR01DK082396 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · fiscal years 2010 to 2014
- Mayo Clinic Center for Translational Science ActivitiesUL1RR024150 · NCRR · MAYO CLINIC ROCHESTER · PI ROBERT A. RIZZA · fiscal years 2006 to 2011
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.